BeOne Medicines (ONC) Other Working Capital Changes (2015 - 2026)

BeOne Medicines (ONC) has 12 years of Other Working Capital Changes data on file, last reported at $6.2 million in Q1 2026.

• On a quarterly basis, Other Working Capital Changes fell 50.1% year-over-year to $6.2 million in Q1 2026; TTM through Mar 2026 was -$4.9 million, a 118.56% decrease from a year earlier, with the FY2025 full-year figure at $1.3 million, down 88.42% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at $6.2 million, up from -$8.3 million in the prior quarter.
• Over the last five years, Other Working Capital Changes for ONC reached as high as $75.1 million in Q2 2025 and fell as low as -$100.6 million in Q3 2025.
• Historically, Other Working Capital Changes has averaged -$6.3 million across 5 years, with a median of -$13.0 million in 2023.
• Across the five-year window, Other Working Capital Changes surged 740.04% in 2023 and tumbled 2251.84% in 2025, its largest moves.
• Year by year, Other Working Capital Changes stood at -$39.0 million in 2022, then soared by 740.04% to $249.6 million in 2023, then plunged by 100.14% to -$353000.0 in 2024, then tumbled by 2251.84% to -$8.3 million in 2025, then jumped by 174.34% to $6.2 million in 2026.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were $6.2 million in Q1 2026, -$8.3 million in Q4 2025, and -$5.5 million in Q3 2025.